Skip to main content
Cara Therapeutics, Inc. (CARA)
15.96
-0.69 (-4.14%)
Inactive · Last trade price on Apr 15, 2025

Cara Therapeutics Revenue

In the year 2024, Cara Therapeutics had annual revenue of $7.14M, down -65.96%. Cara Therapeutics had revenue of $1.46M in the quarter ending December 31, 2024, a decrease of -51.56%.

Revenue (ttm)
$7.14M
Revenue Growth
-65.96%
P/S Ratio
3.40
Revenue / Employee
$713,700
Employees
10
Market Cap
24.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20247.14M-13.83M-65.96%
Dec 31, 202320.97M-20.90M-49.92%
Dec 31, 202241.87M18.84M81.81%
Dec 31, 202123.03M-112.05M-82.95%
Dec 31, 2020135.08M115.20M579.28%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CARA News

More News